Status:
COMPLETED
Low-value Chronic Prescription of Acid Reducing Medication Among Dutch General Practitioners
Lead Sponsor:
Radboud University Medical Center
Conditions:
Dyspepsia
Eligibility:
All Genders
Phase:
NA
Brief Summary
Dyspepsia is a commonly encountered clinical condition in Dutch general practice, which is often treated through the prescription of acid-reducing medication (ARM). However, recent studies indicate th...
Detailed Description
A randomized controlled interventional study was conducted and evaluated using data derived from a subset of practices participating in the Nivel Primary Care Database (Nivel-PCD). The Nivel-PCD conta...
Eligibility Criteria
Inclusion
- the pool of practices that provide their registration data to the Nivel
Exclusion
- None
Key Trial Info
Start Date :
July 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2023
Estimated Enrollment :
26 Patients enrolled
Trial Details
Trial ID
NCT06108817
Start Date
July 1 2022
End Date
October 1 2023
Last Update
November 2 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Radboud University Nijmegen Medical Centre, IQ healthcare
Nijmegen, Netherlands, 6500 HB